How Sopharma Group - can Save You Time, Stress, and Money.

To continue, please click package listed below to let us understand you're not a robot.

As part of the national financial system we have closely followed the developments and turn-arounds of our country, pursuing as a human objective high requirements of quality, safety and effectiveness of medication and spreading out health culture while boosting sector performances and accomplishments.

Sort By: Default Call (A - Z) Name (Z - A) Price (Low > High) Rate (High > Low) Score (Highest) Ranking (Lowest) Liver treatment 80 drops 35 g. $22. 99 Contribute To Cart Liver treatment 80 drops 35 g. Add to Dream List Contribute To Compare 100 g.

Bulgaria's Sopharma looks to eastern Europe for potential Can Be Fun For Anyone

Individual Given That 11 March 2004 2022-04-20 Summary Nation: Bulgaria Org.  Cytisine : Company Sector: Pharmaceuticals & Biotechnology Engagement Tier: Signatory Global Compact Status: Active Ownership: Openly Noted Interaction On Development Responsibility for the material of participants' public communication associated to the 10 Concepts of the UN Global Compact and their application lies with participants themselves and not with the UN Global Compact.

Sopharma - Roids.eu

Ephedrine SOPHARMA 50mg, Buy Ephedrine SOPHARMA 50mg Online

Sopharma

Bulgarian drug maker Sopharma, which was developed in 1933, is active in advancement, production and marketing of over 200 human pharmaceutical items. The company produces primarily cardiovascular drugs, analgesics and vitamins and exports its output to more than 10 countries, with leading locations being Russia and other ex-Soviet states. In July 2000, local company Elpharma established by the engineering and trading company Elektroimpex and Unifarm, a small regional pharmaceuticals company, bought a 66.

Elpharma likewise vowed to invest USD 7. 5 million in Sopharma over the next 3 years. In mid-2003, Sopharma released a debt consolidation of its subsidiaries in Bulgaria by combining with regional drug maker Vramed. The list below year, the Sofia-based company obtained control of regional debt-ridden pharmaceuticals and rose oil producer Balgarska Rosa Sevtopolis.

Excitement About Bulgarian Leading Generics Sopharma Selects Sales Vision

Gramercy Emerging Market Fund bought a 7. 57% stake of Sopharma from its bulk owner for EUR 19. 7 million. The U.S. mutual fund slowly raised its stake in the drug maker to 17% by December 2006. In December 2006, Sopharma purchased for an undisclosed amount a 70% stake of local company Mineral, Commers - the only producer of amorphous silica in the Balkans.